Aerie Pharma (AERI) Tops Q1 EPS by 5c

Aerie Pharma (NASDAQ: AERI) reported Q1 Adj. EPS of ($0.62), $0.05 better than the analyst estimate of ($0.67). Revenue for the quarter came in at $0 , versus $0 reported last year.

For earnings history and earnings-related data on Aerie Pharma (AERI) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• Opera Limited (OPRA) Misses Q2 EPS by 1c ; Offers Guidance
• The Buckle (BKE) Tops Q2 EPS by 7c, Beats on Revenue